Neurolymphomatosis with Spinal Nerve Root Involvement Demonstrated on <sup>18</sup>F-FDG PET/CT
PDF
Cite
Share
Request
Interesting Image
P: 242-243
October 2022

Neurolymphomatosis with Spinal Nerve Root Involvement Demonstrated on 18F-FDG PET/CT

Mol Imaging Radionucl Ther 2022;31(3):242-243
1. Akdeniz University Faculty of Medicine, Department of Nuclear Medicine, Antalya, Turkey
2. Akdeniz University Faculty of Medicine, Department of Radiology, Antalya, Turkey
No information available.
No information available
Received Date: 22.08.2021
Accepted Date: 26.09.2021
Publish Date: 19.10.2022
PDF
Cite
Share
Request

ABSTRACT

A 56 years old woman with a diagnosis of diffuse large B-cell lymphoma had dyspnea, weakness in the left upper extremity and vocal cord paralysis after chemotherapy. She underwent cervical, thoracal and lumbosacral magnetic resonance imaging (MRI) however findings on MRI could not entirely explain the symptoms of the patient. Therefore, the patient underwent 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography and the scan revealed focal symmetrical 18F-FDG uptake on the cervical, thoracal and lumbal spinal nerve roots. Considering the symptoms of the patient and cerebrospinal fluid cytology findings, hypermetabolic spinal nerve roots were interpreted as lymphoma involvement.

References

1
Salm LP, Van der Hiel B, Stokkel MP. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun 2012;33:907-916.
2
Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J 2012;18:463-468.
3
Shree R, Goyal MK, Modi M, Gaspar BL, Radotra BD, Ahuja CK, Mittal BR, Prakash G. The diagnostic dilemma of neurolymphomatosis. J Clin Neurol 2016;12:274-281.
4
Tsang HH, Lee EY, Anthony MP, Khong PL. 18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis. Clin Nucl Med 2012;37:897-898.
5
Davidson T, Kedmi M, Avigdor A, Komisar O, Chikman B, Lidar M, Goshen E, Tzila Zwas S, Ben-Haim S. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Leuk Lymphoma 2018;59:348-356.
6
Strobel K, Fischer K, Hany TF, Poryazova R, Jung HH. Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT. Clin Nucl Med 2007;32:646-648.
7
Singh SS, Mittal BR, Kumar R, Singh H, Balaini N, Goyal M. Primary central nervous system lymphoma with diffuse neurolymphomatosis involving multiple cranial and spinal nerve roots. Clin Nucl Med 2020;45:e285-e287.
8
Byun JM, Kim KH, Kim M, Kim TM, Jeon YK, Park JH, Paik JH, Lee JM, Lee HY, Lee JS, Heo DS, Lee JO. Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience. Leuk Lymphoma 2017;58:2624-2632.